| Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer. | prostate, |
| V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application. | prostate, |
| Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India. | prostate, |
| Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | prostate, |
| Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | prostate, |
| Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos. | prostate, |
| ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. | prostate, |
| ERG oncoprotein expression in prostate carcinoma patients of different ethnicities. | prostate, |
| The oncogene ERG: a key factor in prostate cancer. | prostate, |
| The role of ERG oncogene in prostate cancer | prostate, |
| Genetic inhibition of TMPRSS2-ERG junction oncogene in prostate cancer by means of siRNA has strong antineoplastic effect in a mouse model and in vitro. | prostate, |
| SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. | prostate, |
| Binding of fusion oncogene protein TMPRSS2-ERG to BAF chromatin remodeling complexes mediates prostate oncogenesis. | prostate, |
| Significant association of Erg oncogene protein (ERG) expression was noted with gleason score of prostate cancer patients. | prostate, |
| The oncogenic TLS-ERG fusion protein activates two different sets of genes sharing little similarity when transforms hematopoietic cells and fibroblasts. | None |
| The oncogenic TLS-ERG fusion protein exerts different effects in hematopoietic cells and fibroblasts. | None |
| ERG is a megakaryocytic oncogene. | None |
| Erg oncogenic transcription factor overexpression is associated with global, reproducible, and functionally coherent changes in chromatin organization. | None |
| Oncogene-mediated alterations in chromatin conformation. | None |
| characterization of native ERG and Tmprss2:ERG variants reveals that their different oncogenic potential is affected by the status of the Ets domain and the configuration of the 5_ UTR region | None |